Paige logo

Paige

New York, NY, United States Healthcare & Life Sciences Acquired

Paige is an AI-powered digital pathology company developing artificial intelligence applications for cancer detection and diagnosis. The company leverages proprietary deep learning models and one of the world's largest clinically annotated datasets of digitized pathology slides (7+ million slides) from Memorial Sloan Kettering Cancer Center to develop FDA-cleared and CE-marked diagnostic tools for pathologists and oncologists.

Acquired

Paige has been acquired

Acquired by Tempus AI August 22, 2025 $81.25M

This company is no longer available on our private secondary market.

Overview

Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Founded

2018

Employees

100–200

Total Funding

$301.25M

6 rounds

Latest Valuation

$0.08B

August 22, 2025

Funding

Total raised $301.25M across 6 rounds

Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Last updated 06-25-2026

Latest Round

Type

Acquisition by Tempus

Date

August 22, 2025

Amount

$81.25M

Valuation

$0.08B

Lead Investors

Tempus AI
DateRoundAmount RaisedValuationLead Investors
August 22, 2025 Acquisition by Tempus $81.25M $0.08B Tempus AI
2023 Series C Extension $25M Not disclosed
January 14, 2021 Series C $100M Casdin Capital, Johnson & Johnson Innovation

Leadership

  • Thomas Fuchs

    Co-Founder, Chief Scientist

  • David Klimstra

    Founder, Chief Medical Officer

  • Andy Moye

    Chief Executive Officer

  • Jill Stefanelli

    President, Chief Business Officer

Competitors

Competitor list is illustrative and may be incomplete, stale, or erroneous.

  • PathAI

    AI-powered research tools and services for pathology, delivering diagnosis and treatment of cancer through machine learning approaches

  • Ibex

    AI-based cancer diagnostics company providing diagnostic solutions for pathology that assist in detecting cancer and tissue features

  • Owkin

    Develops AI-based decision-support tools for pathology, including microsatellite instability detection in colorectal cancer

Access live market data

Sign Up

Data collected with AI, which can make mistakes. Please double-check this information.